Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) ...

Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a ...

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

St. Joseph's Hospital was identified as one of the nation's 50 Top Cardiovascular Hospitals®, according to an independent ...

Doctors have found that Covid-19's inflammation can cause long-term cardiovascular issues, such as accelerated plaque buildup ...

Isaac told me afterwards that I started having a seizure. I’d never had one before. I had no idea what was happening to me.” ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

Testosterone worsens the damage caused by a heart attack by increasing the number of white blood cells released from the bone ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new study says. Infection with the COVID virus is associated with rapid growth ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

A new biological patch, designed from heart cells grown in the laboratory, could bring a glimmer of hope in the treatment of ...